27 May, 2017
In case of Revenue Estimates, 11620 analysts have provided their consensus Average Revenue Estimates for Cerus Corporation as 4000. Generally speaking, earnings are expected to grow in coming quarters. Bessemer Grp Inc Inc reported 0% of its portfolio in Cerus Corporation (NASDAQ:CERS). This shows a surprise factor of -5.9%.
Despite the setback, financial analysts from across the sector have reiterated their price targets for Cerus Corporation. That value represents a market adjusting for revenues that have been growing by 10.51 % on a quarterly year/year basis as of the company's last quarterly report. Cerus had a negative return on equity of 76.76% and a negative net margin of 174.76%. According to these analysts, the Low Revenue Estimate for Cerus Corporation is 9.4 Million and the High Revenue Estimate is 13.7 Million.
Several equities research analysts recently commented on CERS shares. BTIG Research reissued a "buy" rating and issued a $8.00 target price on shares of Cerus in a research report on Friday, March 10th. The company is set at a mean analysts' recommendation of 2.00. Zacks Investment Research upgraded Cerus from a "sell" rating to a "hold" rating in a research note on Wednesday, March 8th. Analysts reported that the Price Target for Cerus Corporation might touch $10 high while the Average Price Target and Low price Target is $7.83 and $5 respectively. "Ultimately, through all this investigation into the company's performance the analyst decides if their stock is a "buy", sell" or hold".
Others have even higher price targets and are similarly optimistic about the company's potential. Cerus Corporation (NASDAQ:CERS) has declined 40.83% since May 25, 2016 and is downtrending. 770,315 shares of the company were exchanged. The company has market cap of $11.88 million. The last event - which occurred earlier this week - forced management to once again lower full-year 2017 revenue guidance.
Ratings analysis reveals 50% of Cerus's analysts are positive. If you are viewing this piece on another website, it was stolen and reposted in violation of USA and worldwide copyright legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/05/26/cerus-co-cers-shares-down-4-6-after-earnings-miss-updated-updated.html.
In related news, insider William Mariner Greenman sold 8,786 shares of the firm's stock in a transaction on Wednesday, March 15th.
Shares of biomedical products-manufacturer Cerus Corporation (NASDAQ: CERS) rose over 16% today after investors saw an opportunity in the beaten-down stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. State Street Corp increased its stake in shares of Cerus by 2.2% in the fourth quarter. US Bancorp DE boosted its position in shares of Cerus by 7.3% in the third quarter. The stock price recently experienced a 5-day loss of -26.26% with 0.23 average true range (ATR). Baker BROS. Advisors LP bought a new stake in shares of Cerus during the third quarter valued at $81,061,000. The company has Beta Value of 1.92 and ATR value of 0.24. Lesa Sroufe & Co boosted its position in shares of Cerus by 0.3% in the third quarter.
While looking at the Stock's Performance, Cerus Corporation now shows a Weekly Performance of -34.84%, where Monthly Performance is -56.18%, Quarterly performance is -52.69%, 6 Months performance is -64.37% and yearly performance percentage is -64.12%. Finally, Stephens Inc. AR boosted its position in shares of Cerus by 0.3% in the first quarter. The stock had previously closed at $4.24. Hedge funds and other institutional investors own 68.91% of the company's stock.